Autumn Budget 2018

In this report, Brewin Dolphin react to the Chancellor's 2018 Autumn Budget. 
 
Chancellor Philip Hammond heralded that the era of austerity is coming to an end in his third Budget, after discovering he had significantly more money to play with than he had expected.
 
Key points include:
 
- Pensions, savings and estate planning remain largely untouched, Brewin Dolphin regard this reprieve as a good opportunity to make the most of the tax allowances that already exist.
 
- A planned increase in the tax-free personal allowance to £12,500 and higher-rate threshold to £50,000 will take place a year earlier than planned.
 
- The personal allowance is reduced by £1 for every £2 of income above £100,000. This means your allowance is zero if your income is £123,700 or above.




Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.

Criticaleye Asia Podcast - Su...

Joe Dische, CFO, PropertyGuru Group, shares his perspective on what it means to succeed as a strategic CFO during times of transformation. With over two decades of experience across technology, media and telecom sectors...

Click here to download this insight
Inside the Take-private at Pr...

After a whirlwind journey from the NYSE to private ownership, PropertyGuru CFO Joe Dische reflects on making the hard calls. In this interview with Criticaleye Senior Editor Bridgette Hall, he discusses public vs privat...

Click here to download this insight
A Mindset for Continuous Lear...

After recently closing the page on a wide-ranging executive career, following a six-year stint as CFO of FTSE 250 energy business Drax, Criticaleye Senior Editor Jacob Ambrose Willson finds Andy Skelton in a reflective ...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 167




Google FTSE Women Leaders Review Worldpay NatWest Group Workday NATS Accenture Drax Group plc Salesforce Eightfold AI Lightsource bp Concentrix Palo Alto Networks E.ON UK Rolls-Royce AlixPartners Hitachi Solutions IBM Consulting British Land Legal & General Aldermore Group London Stock Exchange Group GlaxoSmithKline plc